Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FL1Y4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $98.9K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. The company's extensive portfolio includes branded and generic prescription drugs, biologics, and medical consumables across multiple therapeutic categories. Entyvio, a gastrointestinal biologic therapeutic, represents one component of the company's ongoing delivery of specialized pharmaceutical products to military health facilities. The firm has maintained consistent contract awards from DLA since its SAM.gov registration in 2001, demonstrating sustained capability in meeting federal pharmaceutical distribution requirements.
Quick answers
Who was awarded contract SPE2DB25FL1Y4?
SPE2DB25FL1Y4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FL1Y4 worth?
The government has obligated $98,899 on SPE2DB25FL1Y4.
Is contract SPE2DB25FL1Y4 an order under another contract?
Yes. SPE2DB25FL1Y4 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1Y4 competed?
The extent of competition for SPE2DB25FL1Y4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award